VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MNDR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MNDRMobile-health Network Solutions Class A Ordinary Shares
$3.57$87836
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMNDRP/E History

MNDR logoMobile-health Network Solutions Class A Ordinary Shares (MNDR) P/E Ratio History

Insufficient Data

Insufficient historical P/E data to classify valuation. · Data 2026–2026

Current P/E (TTM)
-0.0x
5Y Avg P/E
N/A
Median N/A
5Y Percentile
N/A
PEG Ratio
N/A
TTM EPS$-535.03
Price$3.57
Earnings YieldN/A
EPS Growth (1Y)35.8%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 30, 2026, Mobile-health Network Solutions Class A Ordinary Shares (MNDR) trades at a price-to-earnings ratio of -0.0x, with a stock price of $3.57 and trailing twelve-month earnings per share of $-535.03.

Compared to the Healthcare sector median P/E of 22.9x, MNDR trades at a 100% discount to its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 191.6x.

Relative to the broader market, MNDR trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MNDR DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

MNDR Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
-0.0vs22.9
-100%
Below Sector
vs. S&P 500
-0.0vs25.1
-100%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 36% EPS growth (1Y)

MNDR P/E vs Peers

Virtual and consumer health clinics peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
OPRX logoOPRXOptimizeRx Corporation
$102M20.1-+125%
HIMS logoHIMSHims & Hers Health, Inc.
$7B65.5--4%
DOCS logoDOCSDoximity, Inc.
$4B21.00.40Best-12%
WELL logoWELLWelltower Inc.
$159B163.7--11%
TALK logoTALKTalkspace, Inc.
$871M130.0--
GDRX logoGDRXGoodRx Holdings, Inc.
$988M33.4-+104%
VEEV logoVEEVVeeva Systems Inc.
$29B32.41.78+26%
INVA logoINVAInnoviva, Inc.
$2B7.0Lowest0.68+817%Best

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MNDR — Frequently Asked Questions

Quick answers to the most common questions about buying MNDR stock.

What is MNDR's P/E ratio?

Mobile-health Network Solutions Class A Ordinary Shares (MNDR) trailing twelve-month P/E ratio is -0.0x, based on TTM diluted EPS of $-535.03. The 5-year average P/E is N/A and the historical range spans N/A to N/A.

Is MNDR stock overvalued or undervalued?

MNDR current P/E: -0.0x. 5-year average P/E: N/A. Percentile: N/A.

Is MNDR stock expensive?

MNDR is fairly valued relative to its own history. The current P/E of -0.0x is near the 5-year average of N/A (N/A percentile of historical range).

What is MNDR's historical P/E range?

Over the past 5 years, MNDR's P/E ratio has ranged from N/A to N/A, with a median of N/A and an average of N/A. The current P/E of -0.0x places the stock at the N/A percentile of this range. Full historical data spans 2026–2026.

How does MNDR's P/E compare to the S&P 500?

MNDR current P/E: -0.0x. S&P 500 median P/E: 25.1x.

How does MNDR's valuation compare to Healthcare peers?

Mobile-health Network Solutions Class A Ordinary Shares P/E of -0.0x can be benchmarked against Healthcare peers in the comparison table on this page.

What is MNDR's PEG ratio?

MNDR PEG ratio is N/A, based on a P/E of -0.0x and EPS growth of 35.8%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is MNDR's earnings yield?

MNDR earnings yield is N/A, the inverse of its -0.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

MNDR P/E Ratio History

Quarterly valuation multiple from closing price and trailing EPS

Current-
Period Avg-
Range- - -
Change-
0 quarters- - -